Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease

Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease

Cognitive impairment is common in Parkinson's disease (PD), but often not improved by dopaminergic treatment. New treatment strategies targeting other neurotransmitter deficits are therefore of growing interest. Imaging the brain at rest (‘task-free') provides the opportunity to examine th...

Full description

Bibliographic Details
Main Authors: Borchert, Robin J, Rittman, Timothy, Passamonti, Luca, Ye, Zheng, Sami, Saber, Jones, Simon P, Nombela, Cristina, Vázquez Rodríguez, Patricia, Vatansever, Deniz, Rae, Charlotte L, Hughes, Laura E, Robbins, Trevor W, Rowe, James B
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856878/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856878/

Similar Items